The information on this page was last updated on 6 February 2024.

The Company’s shares are only traded on the London Stock Exchange’s AIM market at present.

The number of shares in issue is 196,546,800 ordinary shares of 10p each. No ordinary shares are held as treasury shares and therefore the total number of voting rights in the Company is 196,546,800.

There are no restrictions on the transfer of securities.

As far as the Company is aware, the percentage of the Company’s issued share capital not in public hands (as defined by the AIM Rules for Companies) is 12.07%.

In so far as the Company has been notified, the Company’s significant (3% or larger) shareholders are as follows.

Name

Number of shares

% of total ISC

Stonehage Fleming Investment Management Ltd 25,737,261

13.09%

Columbia Threadneedle Investments

14,621,737

7.44%

Liontrust Investment Partners LLP

10,322,615

5.25%

Premier Milton Group plc

9,422,372 4.79%

David and Monique Newlands

6,315,000

3.21%

Trafalgar Capital Management

6,184,229 3.15%

Canaccord Genuity Wealth Management

6,000,000 3.05%

 

Directors’ shareholdings

Name

Number of shares

% of total ISC

Mr John McMullan, Medical Director

2,944,966 1.50%
Professor Prasad Godbole, Group Chief Operating Officer (non-board) 2,928,062

1.49%

Mr Simon Stilwell, Chairman

1,966,000

1.00%

Mrs Wendy Lawrence, Chief Executive Officer

872,965

0.44%

Mr Mike Rogers, Non-Executive Director

300,000

0.15%

Mr Tony Bourne, Non-Executive Director

161,000

0.08%

Mr John Charlton, Company Secretary

167,173

0.08%

 

For all shareholder enquiries, please contact John Charlton, Group Company Secretary, at john.charlton@totallyplc.com